SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001140361-21-008965
Filing Date
2021-03-17
Accepted
2021-03-17 20:54:50
Documents
1
Period of Report
2021-03-17

Document Format Files

Seq Description Document Type Size
1 FORM 3 form3.html 3  
1 FORM 3 form3.xml 3 2498
  Complete submission text file 0001140361-21-008965.txt   3889
Mailing Address C/O TOBIRA THERAPEUTICS, INC. 701 GATEWAY BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address
Melincoff Gwen A (Reporting) CIK: 0001614890 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40237 | Film No.: 21752664

Mailing Address 4800 HAMPDEN LANE SUITE 200 BETHESDA MD 20814
Business Address 4800 HAMPDEN LANE SUITE 200 BETHESDA MD 20814 (301) 500-1556
Gain Therapeutics, Inc. (Issuer) CIK: 0001819411 (see all company filings)

IRS No.: 851726310 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations